Medical clearance is the reproductive endocrinologist's decision that your body and health history are compatible with a safe embryo transfer. The decision is made at the IVF clinic working with the intended parents. It usually comes after agency screening and a preliminary match, and before the transfer. It has five parts: a records review, an in-person medical evaluation, an infectious disease panel, a psychological evaluation, and the doctor's final decision. Start to finish, it commonly takes an estimated six to twelve weeks.
If you are reading this before you have contacted any agency, that is a sensible order. Most of what slows clearance down, and most of what complicates it, is visible in your own medical records long before a clinic asks for them.
Surrogate Compass is an independent platform that helps you understand eligibility, pay, the process and how programmes differ before you choose an agency. We do not screen, match or clear anyone. This page explains what the clinic does, so the step is familiar to you before you reach it.
Before You Start: What Medical Clearance Actually Decides
Clearance is a clinical judgement, not an agency form. It is issued by the intended parents' reproductive endocrinologist (RE). It means the RE has reviewed your uterus, your pregnancy history and your general health, and judged them compatible with a safe transfer.
Three things about it are easy to miss.
- It is specific to one clinic and one match. Clearance from one IVF clinic does not transfer to another. A different clinic applies its own protocol.
- It is separate from agency screening. You can pass an agency's application, interview and background check requirements and still not receive medical clearance. The agency decides whether to work with you. The RE decides whether a transfer is medically appropriate.
- It has two required parts. One is the physical and medical evaluation. The other is the psychological evaluation. The RE needs both.
Medical clearance also does not decide some things. It does not settle the legal side, which is handled through the surrogacy contract and your own independent attorney. It does not guarantee that a transfer will work or that a pregnancy will follow. For where clearance fits within the full surrogate screening process, including the steps before it, see that guide.
Step 1: Medical Records Review
The clinic starts with paper. Before anyone examines you, the RE or a nurse reviews your records. The agency coordinator usually collects these with your signed release forms.
Records commonly requested include:
- OB/GYN records for each prior pregnancy and delivery, including prenatal care, complications and how each birth went.
- Cesarean records, including the operative notes. These notes describe the incision type and any problems during surgery. A summary or discharge letter is often not enough.
- Records of prior uterine surgery, such as a myomectomy (fibroid removal) or a D&C.
- General medical history: chronic conditions, current and past medications, and your BMI history.
The review comes before the clinic schedules an in-person visit. A records review alone can lead the RE to decide not to proceed. That is not a judgement about you as a person. It is a judgement about whether this clinic's protocol fits your history.
BMI and age limits are not national rules. Each RE sets parameters for their own clinic, and those parameters differ. A number you have seen on one agency's website may not be the number this clinic uses.
Records retrieval is one of the most common causes of delay at this stage. Some offices respond within days. Others take weeks, or have archived older files, or have closed.
Step 2: The In-Person Medical Evaluation
The visit happens at the intended parents' IVF clinic. That clinic may be in another city or another state, so travel is often involved. Travel costs are usually addressed in the surrogacy agreement, but this is a contract term, not a universal rule. Ask who pays for travel, how it is paid (booked for you or reimbursed), and when.
A typical evaluation includes the following. Clinics vary, and your clinic's protocol decides what is actually done.
- Physical exam. A general health check, vital signs, and height and weight.
- Bloodwork. This includes the infectious disease panel described in Step 3, and often other routine labs.
- Uterine evaluation. Usually a saline infusion sonohysterogram (SIS), sometimes a hysteroscopy. In an SIS, saline is passed through a thin catheter into the uterus while the cavity is viewed by ultrasound. A hysteroscopy uses a small camera passed through the cervix. Both look for fibroids, polyps, scar tissue (adhesions) or structural differences. Many women describe cramping during and after an SIS. Ask the clinic what to expect and whether pain relief is offered.
- Transvaginal ultrasound. This assesses your uterine lining and your ovaries, including an antral follicle count (AFC). You will not be providing eggs, but the AFC adds to the clinic's overall picture of your reproductive health.
- Pap smear, if yours is not current under the clinic's protocol.
- Drug screening.
Plan for the visit to take several hours. Some clinics split it across two days, which may mean an overnight stay. Clinical standards for obstetric and gynecologic evaluation come from professional bodies such as the American College of Obstetricians and Gynecologists, and each clinic builds its own protocol on that kind of guidance. For a closer look at each test, see the guide to surrogate medical screening.
Step 3: Infectious Disease and FDA Compliance Testing
This panel is required regardless of how healthy you are. The reason is regulatory, not personal.
Federal rules in 21 CFR Part 1271 govern human cells and tissues, including reproductive tissue used in embryo transfer. The U.S. Food and Drug Administration administers these rules. Clinics apply the regulation alongside professional guidance from the American Society for Reproductive Medicine, which recommends infectious disease screening for gestational carriers. Together, these are why IVF clinics run a standard panel on every gestational carrier, not only on candidates with a particular history.
The panel commonly includes:
- HIV 1 and 2
- Hepatitis B surface antigen
- Hepatitis C antibody
- HTLV I and II
- Syphilis (RPR or VDRL)
- CMV (cytomegalovirus)
- Gonorrhea and chlamydia
Some clinics add other tests.
A reactive result does not automatically disqualify you. Some results are common. CMV, for example, is a widespread virus, and many adults test positive for past exposure. Other results need confirmatory testing before anyone makes a determination. The RE reviews the results, not the agency.
If you have a partner or spouse, they are typically asked to complete the same panel.
Results also expire. Testing has to fall within a set window before the embryo transfer. If the transfer is delayed significantly, some or all of the panel may need to be repeated.
